Loading...
Have we made progress in the treatment of GVHD?
One reason for the lack of progress in the treatment of acute graft versus host disease (GVHD) is the lack of reliable biomarkers. GVHD of the gastrointestinal (GI) tract is closely associated with non-relapse mortality (NRM) following hematopoietic cell transplantation (HCT). Using an unbiased, lar...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513691/ https://ncbi.nlm.nih.gov/pubmed/23200544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2012.10.010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|